To this end, DBS has shortlisted eight listed companies with a market cap of at least $300 million that will likely benefit from "renewed investor attention" under the programme.
These shortlisted companies meet at least three of the following criteria:
First, an FY2024 net cash level that is equivalent to more than 15% of its market cap.
Next, an attractive dividend yield of more than 4%.
See also: Bank of Singapore prefers Asia ex-Japan equities, neutral on US
Strong earnings growth of at least 10% for the current FY2025.
Forward P/E that is below their respective four-year average.
Last but not least, more than half of their most recent FY2024 revenue generated from within Singapore.
See also: GCMD orchestrates funds for US$20 bil vessel retrofit market
The eight counters shortlisted with this set of filters are further grouped into three main themes.
The first, rotation into overlooked industrials: ComfortDelGro (SGX:C52
) , Hong Leong Asia (SGX:H22) , and SIA Engineering offer exposure to the strong industrials trend with less crowded positioning
The next theme, earnings momentum from structural growth: UMS Integration, Frencken Group (SGX:E28) , and IFAST Corp benefit from sustained semiconductor demand and digital wealth flows
Thirdly, so-called domestic economic proxies: Raffles Medical and PropNex track their respective pillars of Singapore’s economy: healthcare and property.
